gentherm inc - THRM
THRM
Close Chg Chg %
41.66 0.97 2.33%
Closed Market
42.63
+0.97 (2.33%)
Volume: 181.81K
Last Updated:
Nov 21, 2024, 4:00 PM EDT
Company Overview: gentherm inc - THRM
THRM Key Data
| Open $41.56 | Day Range 41.43 - 42.63 |
| 52 Week Range 39.88 - 62.93 | Market Cap $1.29B |
| Shares Outstanding 30.98M | Public Float 30.46M |
| Beta 1.44 | Rev. Per Employee N/A |
| P/E Ratio 19.54 | EPS $2.14 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 239.44K |
THRM Performance
| 1 Week | 0.71% | ||
| 1 Month | 5.57% | ||
| 3 Months | -15.27% | ||
| 1 Year | -8.34% | ||
| 5 Years | 4.00% |
THRM Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
7
Full Ratings ➔
About gentherm inc - THRM
Gentherm, Inc. engages in the designing, development, manufacturing, and marketing of heating, cooling, and ventilating devices. It operates through the Automotive and Medical segments. The Automotive segment designs, develops, produces, and sells automotive seat comfort systems, specialized automotive cable systems, and automotive and non-automotive thermal convenience products. The Medical segment includes global power technologies business, and research and development division. The company was founded by Lon E. Bell in 1991 and is headquartered in Northville, MI.
THRM At a Glance
Gentherm, Inc.
21680 Haggerty Road
Northville, Michigan 48167
| Phone | 1-248-504-0500 | Revenue | 1.47B | |
| Industry | Auto Parts: OEM | Net Income | 40.34M | |
| Sector | Producer Manufacturing | 2023 Sales Growth | 21.95% | |
| Fiscal Year-end | 12 / 2024 | Employees | 14,504 | |
| View SEC Filings |
THRM Valuation
| P/E Current | 19.536 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 42.918 |
| Price to Sales Ratio | 1.179 |
| Price to Book Ratio | 2.562 |
| Price to Cash Flow Ratio | 14.517 |
| Enterprise Value to EBITDA | 11.338 |
| Enterprise Value to Sales | 1.245 |
| Total Debt to Enterprise Value | 0.135 |
THRM Efficiency
| Revenue/Employee | 101,287.645 |
| Income Per Employee | 2,781.509 |
| Receivables Turnover | 5.027 |
| Total Asset Turnover | 1.188 |
THRM Liquidity
| Current Ratio | 2.116 |
| Quick Ratio | 1.482 |
| Cash Ratio | 0.461 |
THRM Profitability
| Gross Margin | 24.522 |
| Operating Margin | 7.509 |
| Pretax Margin | 3.741 |
| Net Margin | 2.746 |
| Return on Assets | 3.262 |
| Return on Equity | 6.127 |
| Return on Total Capital | 4.526 |
| Return on Invested Capital | 4.461 |
THRM Capital Structure
| Total Debt to Total Equity | 38.267 |
| Total Debt to Total Capital | 27.676 |
| Total Debt to Total Assets | 19.987 |
| Long-Term Debt to Equity | 36.976 |
| Long-Term Debt to Total Capital | 26.742 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Gentherm Inc - THRM
Collapse All in section
| All values USD millions. | 2020 | 2021 | 2022 | 2023 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 913.10M | 1.05B | 1.20B | 1.47B | |
Sales Growth
| -6.03% | +14.57% | +15.15% | +21.95% | |
Cost of Goods Sold (COGS) incl D&A
| 643.62M | 741.64M | 916.56M | 1.11B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 41.11M | 38.78M | 44.39M | 50.95M | |
Depreciation
| 31.04M | 29.62M | 33.73M | 42.19M | |
Amortization of Intangibles
| 10.08M | 9.16M | 10.66M | 8.76M | |
COGS Growth
| -5.93% | +15.23% | +23.59% | +20.98% | |
Gross Income
| 269.48M | 304.51M | 288.10M | 360.25M | |
Gross Income Growth
| -6.26% | +13.00% | -5.39% | +25.05% | |
Gross Profit Margin
| +29.51% | +29.11% | +23.92% | +24.52% |
| 2020 | 2021 | 2022 | 2023 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 173.08M | 184.77M | 218.41M | 253.89M | |
Research & Development
| 68.04M | 75.21M | 85.72M | 94.36M | |
Other SG&A
| 105.04M | 109.55M | 132.69M | 159.53M | |
SGA Growth
| -9.30% | +6.75% | +18.21% | +16.24% | |
Other Operating Expense
| 1.77M | 2.50M | 15.92M | (3.96M) | |
Unusual Expense
| 7.55M | 3.86M | 7.96M | 33.59M | |
EBIT after Unusual Expense
| 87.08M | 113.38M | 45.80M | 76.73M | |
Non Operating Income/Expense
| (961.00K) | 3.23M | (348.00K) | (7.84M) | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 4.56M | 2.76M | 7.07M | 13.93M | |
Interest Expense Growth
| -4.28% | -39.50% | +156.20% | +97.16% | |
Gross Interest Expense
| 4.56M | 2.76M | 7.07M | 13.93M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 81.56M | 113.85M | 38.38M | 54.95M | |
Pretax Income Growth
| +37.88% | +39.60% | -66.29% | +43.18% | |
Pretax Margin
| +8.93% | +10.88% | +3.19% | +3.74% | |
Income Tax
| 21.87M | 20.42M | 13.94M | 14.61M | |
Income Tax - Current - Domestic
| 867.00K | 2.18M | 3.66M | 3.92M | |
Income Tax - Current - Foreign
| 20.15M | 18.39M | 17.61M | 23.76M | |
Income Tax - Deferred - Domestic
| (2.27M) | (4.49M) | (6.18M) | (7.05M) | |
Income Tax - Deferred - Foreign
| 3.12M | 4.34M | (1.14M) | (6.02M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 59.69M | 93.43M | 24.44M | 40.34M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 59.69M | 93.43M | 24.44M | 40.34M | |
Net Income Growth
| +59.15% | +56.53% | -73.84% | +65.06% | |
Net Margin Growth
| +6.54% | +8.93% | +2.03% | +2.75% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 59.69M | 93.43M | 24.44M | 40.34M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 59.69M | 93.43M | 24.44M | 40.34M | |
EPS (Basic)
| 1.8273 | 2.824 | 0.7378 | 1.2308 | |
EPS (Basic) Growth
| +61.37% | +54.54% | -73.87% | +66.82% | |
Basic Shares Outstanding
| 32.67M | 33.09M | 33.13M | 32.78M | |
EPS (Diluted)
| 1.8072 | 2.7883 | 0.7295 | 1.22 | |
EPS (Diluted) Growth
| +60.44% | +54.29% | -73.84% | +67.24% | |
Diluted Shares Outstanding
| 33.03M | 33.51M | 33.50M | 33.07M | |
EBITDA
| 135.74M | 156.02M | 98.15M | 161.26M | |
EBITDA Growth
| -3.65% | +14.94% | -37.09% | +64.30% | |
EBITDA Margin
| +14.87% | +14.91% | +8.15% | +10.98% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 66.20 | |
| Number of Ratings | 7 | Current Quarters Estimate | 0.672 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 2.623 | |
| Last Quarter’s Earnings | 0.75 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 2.59 | Next Fiscal Year Estimate | 3.047 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 6 | 5 | 7 | 7 |
| Mean Estimate | 0.67 | 0.62 | 2.62 | 3.05 |
| High Estimates | 0.71 | 0.74 | 2.74 | 3.38 |
| Low Estimate | 0.66 | 0.57 | 2.28 | 2.80 |
| Coefficient of Variance | 2.89 | 11.52 | 6.21 | 6.06 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 3 | 3 | 3 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 4 | 4 | 3 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 1 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Gentherm Inc - THRM
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Gentherm Inc - THRM
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jun 5, 2024 | Yijing Brentano SVP, Strategy, Corp Dev, IR | 18,568 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $54 per share | 1,002,672.00 |
| May 21, 2024 | Barbara J. Runyon SVP, CHRO | 20,445 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $59.63 per share | 1,219,135.35 |
| May 21, 2024 | Wayne Kauffman SVP and General Counsel | 10,265 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $59.63 per share | 612,101.95 |
| May 21, 2024 | Wayne Kauffman SVP and General Counsel | 10,844 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $59.63 per share | 646,627.72 |
| May 21, 2024 | Jaymi Wilson SVP, General Manager NA | 14,344 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $59.63 per share | 855,332.72 |
| May 21, 2024 | Jaymi Wilson SVP, General Manager NA | 14,795 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $59.63 per share | 882,225.85 |
| May 21, 2024 | Elizabeth Meter Director | 10,297 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 21, 2024 | Matteo Anversa EVP, CFO, Treasurer | 26,032 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $59.63 per share | 1,552,288.16 |
| May 21, 2024 | David W. Heinzmann Director | 11,998 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 21, 2024 | Barbara J. Runyon SVP, CHRO | 21,025 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $59.63 per share | 1,253,720.75 |
| May 21, 2024 | Kenneth E. Washington Director | 4,190 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 21, 2024 | Sophie Desormière Director | 32,936 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 21, 2024 | Yijing Brentano SVP, Strategy, Corp Dev, IR | 9,839 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $59.63 per share | 586,699.57 |
| May 21, 2024 | John G. Stacey Director | 17,745 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 21, 2024 | Charles R. Kummeth Director | 16,570 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 21, 2024 | Laura Michele Kowalchik Director | 4,028 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 21, 2024 | Ronald T. Hundzinski Director | 7,931 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 8, 2024 | Phillip M. Eyler President & CEO; Director | 162,317 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $35.5 per share | 5,762,253.50 |
| May 8, 2024 | Phillip M. Eyler President & CEO; Director | 147,317 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $51.47 per share | 7,582,405.99 |
| May 8, 2024 | Phillip M. Eyler President & CEO; Director | 89,684 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |